Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid
{{output}}
Bullous pemphigoid (BP) is a common autoimmune skin disorder caused by autoantibodies targeting BP180. Recent evidence shows that dipeptidyl peptidase-4 inhibitors (DPP4i), used in diabetes management, can induce BP (DPP4i-BP). DPP4i-BP differs from typical BP... ...
